The federal government has secured half a million treatment courses of the experimental covid-19 drug remdesivir, and hospitals will pay no more than $3,200 per average treatment course, the government and Gilead Sciences announced. Preliminary research shows the drug may reduce the length of covid-19 hospital stays as much as one-third.
Buffalo Trace Distillery in Frankfort, not on the official Kentucky Bourbon Trail but very popular, said it would resume tours Wednesday, with advance registration required. "Guests will also be asked to wear a face mask. For anyone who forgets theirs, one will be provided," the distillery says. "Tours and events will be kept to small, comfortable groups to allow for social distancing."
The percentage of positive tests for the virus in Kentucky has remained stable for the past month, tweets Daniel Desrochers of the Lexington Herald-Leader, with this chart (adapted by Kentucky Health News):
Buffalo Trace Distillery in Frankfort, not on the official Kentucky Bourbon Trail but very popular, said it would resume tours Wednesday, with advance registration required. "Guests will also be asked to wear a face mask. For anyone who forgets theirs, one will be provided," the distillery says. "Tours and events will be kept to small, comfortable groups to allow for social distancing."
The percentage of positive tests for the virus in Kentucky has remained stable for the past month, tweets Daniel Desrochers of the Lexington Herald-Leader, with this chart (adapted by Kentucky Health News):
from KENTUCKY HEALTH NEWS https://ift.tt/38d1DmK
0 Response to "Coronavirus update: Hospitals will get drug than can shorten covid-19 stays by a third; Kentucky's positive-test rate is stable-HEALTHYLIVE"
Post a Comment